Novel method for determination of methoxphenidine and its main metabolite in biological samples
The result's identifiers
Result code in IS VaVaI
<a href="https://www.isvavai.cz/riv?ss=detail&h=RIV%2F60461373%3A22340%2F22%3A43924053" target="_blank" >RIV/60461373:22340/22:43924053 - isvavai.cz</a>
Alternative codes found
RIV/60461373:22810/22:43924053
Result on the web
<a href="https://www.sciencedirect.com/science/article/abs/pii/S2352007822003742" target="_blank" >https://www.sciencedirect.com/science/article/abs/pii/S2352007822003742</a>
DOI - Digital Object Identifier
<a href="http://dx.doi.org/10.1016/j.toxac.2022.06.302" target="_blank" >10.1016/j.toxac.2022.06.302</a>
Alternative languages
Result language
angličtina
Original language name
Novel method for determination of methoxphenidine and its main metabolite in biological samples
Original language description
Methoxphenidine (MXP) is new psychoactive substance belonging to the group of dissociative anesthetics. It appeared on the black market in 2013, and MXP intoxications have been reported with at least three deaths since then. To understanding the mechanism of toxicity and effects of MXP, it is important to know its pharmacological properties (e.g. toxicity, activity on receptors and ADME) and metabolism which may be further exploited to study its mechanism of action in vivo. Metabolism of such compound may be useful not only in toxicological screenings, but together with pharmacokinetic and pharmacodynamic data it enhances the knowledge how these substances may affect the living organism. It is still very little information on the MXP and a method for analysis of biological samples (e.g. brain, liver, lungs and serum) remain to be developed.
Czech name
—
Czech description
—
Classification
Type
J<sub>ost</sub> - Miscellaneous article in a specialist periodical
CEP classification
—
OECD FORD branch
10406 - Analytical chemistry
Result continuities
Project
<a href="/en/project/NU21-04-00307" target="_blank" >NU21-04-00307: Psilocybin versus ketamine – fast acting antidepressant strategies in treatment-resistant depression</a><br>
Continuities
P - Projekt vyzkumu a vyvoje financovany z verejnych zdroju (s odkazem do CEP)
Others
Publication year
2022
Confidentiality
S - Úplné a pravdivé údaje o projektu nepodléhají ochraně podle zvláštních právních předpisů
Data specific for result type
Name of the periodical
Toxicologie Analytique et Clinique
ISSN
2352-0078
e-ISSN
2352-0086
Volume of the periodical
34
Issue of the periodical within the volume
3
Country of publishing house
FR - FRANCE
Number of pages
2
Pages from-to
"S175"
UT code for WoS article
—
EID of the result in the Scopus database
—